Learn More
Medchemexpress LLC MET kinase-IN-4 | 888719-03-7 | 99.0% | 458.42 | 25 MG

Supplier: Medchemexpress LLC 25MGHY18309
MET kinase-IN-4 is an orally active Met kinase inhibitor with potent Met kinase inhibitory activity (IC50 value of 1.9 nM). It can be used for cancer research. It also inhibits Flt-3 and VEGFR-2 kinases with IC50 values of 4 nM and 27 nM, respectively. MET kinase-IN-4 (3 μM) shows good metabolic stability in both human and mouse liver microsomes.
- Orally active Met kinase inhibitor.
- Potent Met kinase inhibitory activity with an IC50 value of 1.9 nM.
- Inhibits Flt-3 and VEGFR-2 kinases with IC50 values of 4 nM and 27 nM, respectively.
- Shows good metabolic stability in both human and mouse liver microsomes.
- Possesses a favorable pharmacokinetic profile in mice.
- Demonstrates significant in vivo antitumor activity in the GTL-16 human gastric carcinoma xenograft model.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.